MHC-E-restricted CD8+ T cells target Hepatitis B virus-infected human hepatocytes

Currently 247 million people are living with chronic HBV infection (CHB), and the development of novel curative treatments is urgently needed. Immunotherapy is an attractive approach to treat CHB, yet therapeutic approaches to augment the endogenous HBV-specific T cell response in CHB patients have...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Immunol
Main Authors: Burwitz, Benjamin J., Hashiguchi, Patrick K., Mansouri, Mandana, Meyer, Christine, Gilbride, Roxanne M., Biswas, Sreya, Womack, Jennie L., Reed, Jason S., Wu, Helen L., Axthelm, Michael K., Hansen, Scott G., Picker, Louis J., Früh, Klaus, Sacha, Jonah B.
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8109620/
https://ncbi.nlm.nih.gov/pubmed/32161099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1900795
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki